Chevron Corporation vs NOV Inc. — Stock Comparison
Q·Score Breakdown
6.4
Neutral
Overall
4.9
Bearish
Quality
Health
Growth
Valuation
Sentiment
CVX
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ earnings contracting 44% year-over-year.
NOV
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ revenue declining 2% year-over-year.
Analyst Consensus
BUY
Target $213.30 (+11.9%)
23 analysts
HOLD
Target $21.10 (+6.2%)
20 analysts
Fundamentals
CVX
NOV
33.2×
Trailing P/E
79.4×
16.1×
Forward P/E
14.8×
5.9%
Profit Margin
1.0%
42.4%
Gross Margin
20.6%
—
ROE
1.5%
3.5%
Revenue Growth
-2.4%
-44.4%
Earnings Growth
-73.7%
0.59
Beta
0.94
—
Price / Book
—
$379.7B
Market Cap
$7.1B
$134 – $215
52-Week Range
$12 – $21
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →